Vimarsana
Biggest News Aggregation in the World

Page 6 - Plastic Surgeons News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Plastic Surgeons. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Plastic Surgeons Today - Breaking & Trending Today

What's The Deal With The 'Fake Botox' That's Making Everyone Sick? - Vimarsana News

What's The Deal With The 'Fake Botox' That's Making Everyone Sick?

Counterfeit botox has cropped up in 11 states and caused blurred vision, shortness of breath and even hospitalization.

Source: yahoo.com
San Francisco Events Focus on Art, Fashion and Activism - Vimarsana News

San Francisco Events Focus on Art, Fashion and Activism

The latest Art Bash at SFMOMA raised $3 million, while guests of FiSF and HRF's Wear Your Values explore couture history and ethical fashion.

Source: wwd.com
Caliway Announced CBL-514 Phase 2 Study for Cellulite Treatment Met All Primary and Secondary Endpoints - Vimarsana News

Caliway Announced CBL-514 Phase 2 Study for Cellulite Treatment Met All Primary and Secondary Endpoints

CBL-514 is the first product to treat cellulite at the raised areas. Currently, there is no effective and safe cellulite treatment on the market. The global...

Caliway Announced CBL-514 Phase 2 Study for Cellulite Treatment Met All Primary and Secondary Endpoints - Vimarsana News

Caliway Announced CBL-514 Phase 2 Study for Cellulite Treatment Met All Primary and Secondary Endpoints

CBL-514 is the first product to treat cellulite at the raised areas.Currently, there is no effective and safe cellulite treatment on the market. The global market for cellulite treatment is estimated to expand to $7.37 billion in 2034.CBL-0201EFP...

Caliway Announced CBL-514 Phase 2 Study for Cellulite Treatment Met All Primary and Secondary Endpoints - Vimarsana News

Caliway Announced CBL-514 Phase 2 Study for Cellulite Treatment Met All Primary and Secondary Endpoints

NEW TAIPEI CITY, April 26, 2024 /PRNewswire/ -- Caliway Biopharmaceuticals (Caliway) today announced the topline results of the CBL-0201EFP Phase 2 study,